Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin–Bound Paclitaxel in Rats
Abstract.: Nanoparticle albumin–bound paclitaxel (nab-paclitaxel) is delivered to tumors and increases antitumor activity compared with solvent-based paclitaxel. However, in a clinical trial, higher and lower rates of peripheral neuropathy and neutropenia were observed. In this study, we compared th...
Main Authors: | Yuji Yamashita, Nobuaki Egashira, Ken Masuguchi, Soichiro Ushio, Takehiro Kawashiri, Ryozo Oishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319306437 |
Similar Items
-
Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
by: Shunsuke Fujita, et al.
Published: (2015-01-01) -
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
by: Takehiro Kawashiri, et al.
Published: (2021-08-01) -
Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
by: Shirahama Masafumi, et al.
Published: (2012-04-01) -
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01) -
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats
by: Shota Yamamoto, et al.
Published: (2015-09-01)